FaStep® Rapid Diagnostic Test for
COVID-19
Assure has developed the first and only FDA approved rapid point-of-care lateral flow immunoassays to aid in the diagnosis of coronavirus infection. The test detects both early marker and late marker, IgM/IgG antibodies in human finger-prick (capillary) or venous whole blood, serum, and plasma samples.
The COVID-19 IgM/IgG Rapid Test demonstrates a combined sensitivity and specificity of 100% and ~99% respectively, making it one of the most accurate and reliable tests in the world.
FaStep COVID-19 IgG/IgM Rapid Test Device Demonstration
GPO+ MEMBERS
Sign in to you your GPOPlus+ account to save.
NOT A MEMBER YET?
Get Your FREE Membership Discount Instantly!
Purchasing Information
PHONE:
+1 (702) 620-9756
EMAIL:
MEMBERS:
NON-MEMBERS:
GPO+ MEMBERS
Sign in to you your GPOPlus+ account to save.
NOT A MEMBER YET?
Get Your FREE Membership Discount Instantly!
PLEASE NOTE THIS IS NOT FOR INDIVIDUAL PURCHASE OR USE. THIS IS STRICTLY FOR BUSINESSES AND GOVERNMENTAL ORGANIZATIONS.
Any orders shipped to a personal address or non-medical business address will be voided and refunded.
Downloads
Resources
Authorized by
The U.S. Food and Drug Administration
“Authorizing point-of-care serology tests will enable more timely and convenient results for individuals who want to understand if they have previously been infected with the virus that causes COVID-19,”
– FDA Commissioner Stephen M. Hahn, M.D.